Sunil Thomas
Affiliations: | Lankenau Institute for Medical Research |
Google:
"Sunil Thomas"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| George C. Prendergast | research scientist | Lankenau Institute for Medical Research |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Thomas S, Prendergast GC. (2023) Gut-brain connections in neurodegenerative disease: immunotherapeutic targeting of Bin1 in inflammatory bowel disease and Alzheimer's disease. Frontiers in Pharmacology. 14: 1183932 |
| Thomas S, Dilbarov N, Kelly J, et al. (2023) Diet effects on colonic health influence the efficacy of Bin1 mAb immunotherapy for ulcerative colitis. Scientific Reports. 13: 11802 |
| Muller AJ, Thomas S, Prendergast GC. (2023) A Brief Overview of Cancer Vaccines. Cancer Journal (Sudbury, Mass.). 29: 34-37 |
| Thomas S, Mercogliano G, Prendergast GC. (2022) Bin1 targeted immunotherapy alters the status of the enteric neurons and the microbiome during ulcerative colitis treatment. Plos One. 17: e0276910 |
| Dey S, Mondal A, DuHadaway JB, et al. (2021) IDO1 Signaling Through GCN2 in a Subpopulation of Gr-1+ Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization. Cancer Immunology Research |
| Dey S, Mondal A, DuHadaway JB, et al. (2020) Abstract 1474: IDO1 signaling supports inflammatory neovascularization Cancer Research. 80: 1474-1474 |
| Thomas S, Laury-Kleintop L, Prendergast GC. (2019) Reliable detection of indoleamine 2,3 dioxygenase-1 in murine cells and tissues. Methods in Enzymology. 629: 219-233 |
| Thomas S, Hoxha K, Tran A, et al. (2019) Bin1 antibody lowers the expression of phosphorylated Tau in Alzheimer's disease. Journal of Cellular Biochemistry |
| Thomas S, Hoxha K, Alexander W, et al. (2018) Intestinal barrier tightening by a cell-penetrating antibody to Bin1, a candidate target for immunotherapy of ulcerative colitis. Journal of Cellular Biochemistry |
| Fox E, Oliver T, Rowe M, et al. (2018) Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer. Frontiers in Oncology. 8: 370 |